nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A New Model of Prescription to Nonprescription Reclassification: The Calcipotriol Case Study
|
Gauld, Natalie |
|
2012 |
34 |
6 |
p. 1324-1332 9 p. |
artikel |
2 |
Assessment of Pharmacodynamic Equivalence and Tolerability of Lanthanum Carbonate Oral Powder and Tablet Formulations: A Single-Center, Randomized, Open-Label, 2-Period Crossover Study in Healthy Subjects
|
Pierce, David |
|
2012 |
34 |
6 |
p. 1290-1300.e2 128711 p. |
artikel |
3 |
Clinical and Cost Effectiveness of Bevacizumab + FOLFIRI Combination Versus FOLFIRI Alone as First-Line Treatment of Metastatic Colorectal Cancer in South Korea
|
Lee, Eui-Kyung |
|
2012 |
34 |
6 |
p. 1408-1419 12 p. |
artikel |
4 |
Comparative Fasting Bioavailability of Dispersible and Conventional Tablets of Risperidone: A Single-Dose, Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Male Chinese Volunteers
|
Huang, Mingzhu |
|
2012 |
34 |
6 |
p. 1432-1439 8 p. |
artikel |
5 |
Cost-Effectiveness Model of Use of Genetic Testing as an Aid in Assessing the Likely Benefit of Aspirin Therapy for Primary Prevention of Cardiovascular Disease
|
Shiffman, Dov |
|
2012 |
34 |
6 |
p. 1387-1394 8 p. |
artikel |
6 |
Cost-Effectiveness of Denosumab Versus Zoledronic Acid in the Management of Skeletal Metastases Secondary to Breast Cancer
|
Snedecor, Sonya J. |
|
2012 |
34 |
6 |
p. 1334-1349 16 p. |
artikel |
7 |
Cost-Effectiveness of Escitalopram in Major Depressive Disorder in the Dutch Health Care Setting
|
Nuijten, Mark J.C. |
|
2012 |
34 |
6 |
p. 1364-1378 15 p. |
artikel |
8 |
Costs and Clinical Outcomes Associated with Use of Ranolazine for Treatment of Angina
|
Phelps, Charles E. |
|
2012 |
34 |
6 |
p. 1395-1407.e4 1.4068606E7 p. |
artikel |
9 |
Efficacy and Safety Profile Evaluation of Acarbose Alone and in Association With Other Antidiabetic Drugs: A Systematic Review
|
Derosa, Giuseppe |
|
2012 |
34 |
6 |
p. 1221-1236 16 p. |
artikel |
10 |
Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies
|
Lee, Howard |
|
2012 |
34 |
6 |
p. 1273-1289 17 p. |
artikel |
11 |
Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
|
Aroda, Vanita R. |
|
2012 |
34 |
6 |
p. 1247-1258.e22 1.258E25 p. |
artikel |
12 |
Long-Term Effects of Adding Exenatide to a Regimen of Metformin and/or Sulfonylurea in Type 2 Diabetes: An Uncontrolled, Open-Label Trial in Hungary
|
Iványi, Tibor |
|
2012 |
34 |
6 |
p. 1301-1313 13 p. |
artikel |
13 |
Loteprednol Etabonate Suspension 0.2% Administered QID Compared With Olopatadine Solution 0.1% Administered BID in the Treatment of Seasonal Allergic Conjunctivitis: A Multicenter, Randomized, Investigator-Masked, Parallel Group Study in Chinese Patients
|
Gong, Lan |
|
2012 |
34 |
6 |
p. 1259-1272.e1 11462 p. |
artikel |
14 |
Management of Acute Pharyngitis in Children: Summary of the Italian National Institute of Health Guidelines
|
Chiappini, Elena |
|
2012 |
34 |
6 |
p. 1442-1458.e2 144359 p. |
artikel |
15 |
Pharmacokinetic Profile of Beclomethasone Dipropionate Hydrofluoroalkane After Intranasal Administration Versus Oral Inhalation in Healthy Subjects: Results of a Single-Dose, Randomized, Open-Label, 3-Period Crossover Study
|
Ratner, Paul H. |
|
2012 |
34 |
6 |
p. 1422-1431 10 p. |
artikel |
16 |
Restrictive Drug Coverage Policies can Induce Substantial Drug Exposure Misclassification in Pharmacoepidemiologic Studies
|
Gamble, John-Michael |
|
2012 |
34 |
6 |
p. 1379-1386.e3 1.384622E6 p. |
artikel |
17 |
System-Wide Implementation of the Use of an Extended-Infusion Piperacillin/Tazobactam Dosing Strategy: Feasibility of Utilization From a Children's Hospital Perspective
|
Nichols, Kristen R. |
|
2012 |
34 |
6 |
p. 1459-1465 7 p. |
artikel |
18 |
Ticagrelor: Oral Reversible P2Y12 Receptor Antagonist for the Management of Acute Coronary Syndromes
|
Cheng, Judy W.M. |
|
2012 |
34 |
6 |
p. 1209-1220 12 p. |
artikel |
19 |
Treatment and Clinical Outcomes of Urinary Tract Infections Caused by KPC-Producing Enterobacteriaceae in a Retrospective Cohort
|
Alexander, Bryan T. |
|
2012 |
34 |
6 |
p. 1314-1323 10 p. |
artikel |
20 |
Update on Potential Drugs for the Treatment of Diabetic Kidney Disease
|
Shepler, Brian |
|
2012 |
34 |
6 |
p. 1237-1246 10 p. |
artikel |
21 |
Utilization and Cost in Clinical Practice of Darbepoetin Alfa and Epoetin Alfafor Anemia Concomitant With Chemotherapy
|
Berger, Ariel |
|
2012 |
34 |
6 |
p. 1350-1363 14 p. |
artikel |